+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


A-Share Listed Pharmaceutical Companies - Profiles and Financial Data

  • ID: 4226183
  • Company Profile
  • April 2017
  • Region: China
  • 650 pages
  • China Research & Intelligence
1 of 4
In 2016, the Revenue of the Chemical Pharmaceutical Industry Reached CNY 1,256.96 Billion, Up by 9.9% YOY

With the growing Chinese economy and increasing residents' income, people's purchasing power of pharmaceuticals has been enhanced. China's aging population also promotes demand for pharmaceuticals. In 2016, revenues from main businesses of China's pharmaceutical industry reached CNY 2,963.59 billion, up by 9.9% YOY; profits were CNY 321.64 billion, up by 15.6% YOY. Among sub-industries, active pharmaceutical ingredients (API), pharmaceutical preparations and medical devices maintained strong profitability, witnessing their profits grow by 25.9%, 16.8% and 32.3%, respectively. The revenues from main businesses of pharmaceutical preparations, TCM decoction pieces processing, sanitary materials & medical products and medical devices industries were higher than average and grew by 10.8%, 12.7%, 11.5% and 13.3%, respectively.

In 2016, the revenue of the chemical pharmaceutical industry reached CNY 1,256.96 billion, up by 9.9% YOY; profits were CNY 139.57 billion, up by 19.6% YOY; export delivery value was CNY 79.26 billion, up by 4.5% YOY. The operating revenue of API manufacturers totalled to CNY 503.49 billion, up by 8.4% YOY; profits were CNY 44.53 billion, up by 25.9% YOY; export delivery value was CNY 64.87 billion, up by 7.4% YOY.

CRI expects that in the next few years, demand for pharmaceuticals will rise with increasing residents' income, upgrading consumption, aging population, accelerating urbanization and improving healthcare system, promoting the development of China's pharmaceutical industry.

In this report, the researcher analyzes 161 pharmaceutical enterprises listed in A-share market in China.

The report is composed of two parts: the first part is enterprise profiles and the second part is the operation status of these enterprises in the recent decade (presently 2006 to 2016, we will update it to the latest as time goes by).

The operation status is demonstrated from the following perspectives: (1)financial indexes, such as earnings per share, book value per share (BPS), sales per share, net cash flow per share, return on net worth and debt to asset ratio; (2) indexes on the income statement, such as revenue, operating profit, net profit and EBIT; (3) indexes on the income statement, such as revenue, operating profit, net profit and EBIT; (4) indexes on the balance sheet, such as liquid asset, fixed asset, current liability, non-current liability, capital reserve and shareholders' equity.

Note: Product cover images may vary from those shown
2 of 4

(1) Financial Indexes

  • Earnings per Share
  • Book Value per Share (BPS)
  • Sales per Share (SPS)
  • Net Cash Flow per Share from Operations
  • Net Cash Flow per Share (CNY)
  • Return on Net Worth
  • Net Profit Margin on Total Assets
  • Return on Invested Capital (ROIC) (%)
  • Gross Profit Margin on Sales (%)
  • Net Profit Margin on Sales (%)
  • EBIT Margin (%)
  • EBITDA Margin (%)
  • Debt to Asset Ratio (%)
  • Total Asset Turnover (times)
  • Cash/Operating Income Received from Sales of Goods or Services
  • YOY Growth Rate of Operating Revenue (%)
  • YOY Growth Rate of Operating Profit (%)
  • YOY Growth Rate of Net Profit Attributable to Shareholders of Parent Company (%)

(2) Summary of Income Statement

  • Gross Revenue (CNY, million)
  • Total Operating Costs (CNY, million)
  • Revenue (CNY, million)
  • Operating Profit (CNY, million)
  • Total Profit (CNY, million)
  • Net Profit (CNY, million)
  • Net Profit Attributable to Shareholders of Parent Company (CNY, million)
  • Non-recurring Items (CNY, million)
  • Net Profit Deducting Non-recurring Items (CNY, million)
  • R&D Costs (CNY, million)
  • Earnings Before Interest and Tax (EBIT) (CNY, million)
  • Earnings Before Interest, Taxes, Depreciation and Amortization (EBITDA) (CNY, million)

(3) Summary of Balance Sheet

  • Liquid Asset (CNY, million)
  • Fixed Asset (CNY, million)
  • Long-term Equity Investment
  • Total Assets (CNY, million)
  • Liquid Liability (CNY, million)
  • Non-current Liability (CNY, million)
  • Total Liability (CNY, million)
  • Capital Reserve (CNY, million)
  • Surplus Reserve (CNY, million)
  • Undistributed Profit (CNY, million)
  • Shareholders' Equity (CNY, million)
  • Equity Attributable to Shareholders of Parent Company (CNY, million)

(4) Summary of Cash Flow Statement

  • Cash Received from Sales of Goods and Services (CNY, million)
  • Cash Flow from Operations (CNY, million)
  • Cash Paid to Purchase Fixed Assets, Intangible Assets and Other Long-term Assets (CNY, million)
  • Cash Paid for Investments (CNY, million)
  • Cash Flow from Investments (CNY, million)
  • Cash Received from Investors (CNY, million)
  • Cash Received from Borrowings (CNY, million)
  • Cash Flow from Financing (CNY, million)
  • Net Increase of Cash and Cash Equivalents (CNY, million)
  • Cash and Cash Equivalents, End of Period (CNY, million)
  • Depreciation and Amortization (CNY, million)
Note: Product cover images may vary from those shown
3 of 4
  •  Autobio Diagnostics Co., Ltd. (603658.SH)
  •  Beijing Tongrentang Co., Ltd. (600085.SH)
  •  Buchang Pharmaceutical Co., Ltd. (603858.SH)
  •  China Resources Double-Crane Pharmaceutical Co., Ltd. (600062.SH)
  •  Chongqing Taiji Industry (Group) Co., Ltd. (600129.SH)
  •  Furen Pharmaceutical Group Industry Co., Ltd. (600781.SH)
  •  Ginwa Enterprise (Group) Inc. (600080.SH)
  •  Guangxi Wuzhou Zhongheng Group Co., Ltd. (600252.SH)
  •  Guangyuyuan Chinese Herbal Medicine Co., Ltd. (600771.SH)
  •  Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (600332.SH)
  •  Guizhou Yibai  Pharmaceutical Group Co., Ltd. (600594.SH)
  •  HPGC Renmintongtai Pharmaceutical Corporation (600829.SH)
  •  Hainan Poly Pharm. Co., Ltd. (300630.SZ)
  •  Hangzhou Tianmushan Pharmaceutical Enterprise Co., Ltd. (600671.SH)
  •  Harbin Pharmaceutical Group Holding Co., Ltd. (600664.SH)
  •  Henan Lingrui Pharmaceutial Co., Ltd. (600285.SH)
  •  Henan Taloph Pharmaceutical Stock Co., Ltd. (600222.SH)
  •  Hubei Jumpcan Pharmaceutical Co., Ltd. (600566.SH)
  •  Humanwell Healthcare Group Co., Ltd. (600079.SH)
  •  Hunan Fangsheng Pharmaceutical Co., Ltd. (603998.SH)
  •  Jiangsu Hengrui Medicine Co., Ltd. (600276.SH)
  •  Jiangsu Kanion Pharmaceutical Co., Ltd. (600557.SH)
  •  Jiangsu Lianhuan Pharmaceutical Co., Ltd. (600513.SH)
  •  Jiangzhong Pharmaceutical Co., Ltd. (600750.SH)
  •  Jianmin Pharmaceutical Group Co., Ltd. (600976.SH)
  •  Jinyu Bio-Technology Co., Ltd. (600201.SH)
  •  Joincare Pharmaceutical Group Industry Co., Ltd (600380.SH)
  •  KPC Pharmaceuticals, Inc. (600422.SH)
  •  Kangmei Pharmaceutical Co., Ltd. (600518.SH)
  •  Lionco Pharmaceutical Group Co., Ltd. (603669.SH)
  •  Mayinglong Pharmaceutical Group Co., Ltd. (600993.SH)
  •  Nanjing Hicin Pharmaceutical Co., Ltd. (300584.SZ)
  •  North China Pharmaceutical Company Ltd. (600812.SH)
  •  Pengqi Technology Development Co., Ltd. (600614.SH)
  •  Pulike Biological Engineering, Inc. (603566.SH)
  •  Qinghai Spring Medicinal Resources Technology Co., Ltd. (600381.SH)
  •  Shandong Lukang International Trading Co., Ltd. (600789.SH)
  •  Shandong Sito Bio-technology Co., Ltd. (300583.SZ)
  •  Shanghai Fosun Pharmaceutical Co., Ltd. (600196.SH)
  •  Shanghai Hile Bio-Technology Co., Ltd. (603718.SH)
  •  Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. (600613.SH)
  •  Shanghai Shyndec Pharmaceutical Co., Ltd. (600420.SH)
  •  Shenyang Xingqi Pharmaceutical Co., Ltd. (300573.SZ)
  •  Tasly Pharmaceutical Group Co., Ltd. (600535.SH)
  •  Tianjin Tianyao Pharmaceuticals Co., Ltd. (600488.SH)
  •  Tianjin Zhongxin Pharmaceutical Group Corporation Limited (600329.SH)
  •  Tibet Rhodiola Pharmaceutical Holding Company (600211.SH)
  •  Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SH)
  •  Wuhan Thalys Medical Technology Inc. (603716.SH)
  •  Yabao Pharmaceutical Group Co., Ltd. (600351.SH)
  •  ZBD Pharmaceutical Co., Ltd. (603567.SH)
  •  Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. (600436.SH)
  •  Zhejiang Cheng Yi Pharmaceutical Co., Ltd. (603811.SH)
  •  Zhejiang Chimin Pharmaceutical Co., Ltd. (603222.SH)
  •  Zhejiang Conba Pharmaceutical Co., Ltd. (600572.SH)
  •  Zhejiang Hisun Pharmaceutical Co., Ltd. (600267.SH)
  •  Zhejiang Huahai Pharmaceutical Co., Ltd. (600521.SH)
  •  Zhejiang Jiuzhou Pharmaceutical Co., Ltd. (603456.SH)
  •  Zhejiang Medicine Co., Ltd. (600216.SH)
  •  Zhejiang Shapuaisi Pharmaceutical Co., Ltd. (603168.SH)
  •  Zhejiang Starry Pharmaceutical Co., Ltd. (603520.SH)
  •  Zhuzhou Qianjin Pharmaceutical Co., Ltd. (600479.SH)
  • Anhui Anke Biotechnology (Group) Co., Ltd. (300009.SZ)
  • Anhui BBCA Pharmaceutical Co., Ltd. (000153.SZ)
  • Anhui Huangshan Capsule Co., Ltd. (002817.SZ)
  • Anhui Sunhere Pharmaceutical Excipients Co., Ltd. (300452.SZ)
  • Apeloa Pharmaceutical Co., Ltd. (000739.SZ)
  • Asymchem Laboratories (Tianjin) Co., Ltd. (002821.SZ)
  • Baotou Dongbao Bio-Tech Co., Ltd. (300239.SZ)
  • Beijing Beilu Pharmaceutical Co., Ltd. (300016.SZ)
  • Beijing SL Pharmaceutical Co., Ltd. (002038.SZ)
  • Beijing Science Sun Pharmaceutical Co., Ltd. (300485.SZ)
  • Beijing Strong Biotechnologies, Inc. (300406.SZ)
  • Betta Pharmaceuticals Co., Ltd. (300558.SZ)
  • Chasesun Pharmaceutical Co., Ltd. (300026.SZ)
  • Chengdu Taihe Health Technology Group Inc., Ltd. (000790.SZ)
  • Chongqing LUMMY Pharmaceutical Co., Ltd. (300006.SZ)
  • Dezhan Healthcare Company Limited (000813.SZ)
  • Dong-E-E-Jiao Co., Ltd. (000423.SZ)
  • Fuan Pharmaceutical (Group) Co., Ltd. (300194.SZ)
  • Fujian Cosunter Pharmaceutical Co., Ltd. (300436.SZ)
  • Gansu Longshenrongfa Pharmaceutical Industry Co., Ltd. (300534.SZ)
  • Guanfu Holdings Co., Ltd. (002102.SZ)
  • Guangdong Jiaying Pharmaceutical Co., Ltd. (002198.SZ)
  • Guangdong Taiantang Pharmaceutical Co., Ltd. (002433.SZ)
  • Guangdong Zhongsheng Pharmaceutical Co., Ltd. (002317.SZ)
  • Guilin Sanjin Pharmaceutical Co., Limited (002275.SZ)
  • Guizhou Bailing Group Pharmaceutical Co., Ltd. (002424.SZ)
  • Guizhou Xinbang Pharmaceutical Co., Ltd. (002390.SZ)
  • Hainan Haiyao Co., Ltd. (000566.SZ)
  • Hainan Shuangcheng Pharmaceutical Co., Ltd. (002693.SZ)
  • Haisco Pharmaceutical Group Co., Ltd. (002653.SZ)
  • Harbin Gloria Pharmaceuticals Co., Ltd. (002437.SZ)
  • Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (300255.SZ)
  • Hengkang Medical Group Co., Ltd. (002219.SZ)
  • Honz Pharmaceutical Co., Ltd. (300086.SZ)
  • Huadong Medicine Co., Ltd. (000963.SZ)
  • Hubei Guangji Pharmaceutical Co., Ltd. (000952.SZ)
  • Hunan Er-Kang Pharmaceutical Co., Ltd. (300267.SZ)
  • Hunan Hansen Pharmaceutical Co., Ltd. (002412.SZ)
  • Hunan Jingfeng Pharmaceutical Co., Ltd. (000908.SZ)
  • Hybio Pharmaceutical Co., Ltd. (300199.SZ)
  • Inner Mongolia Furui Medical Science Co., Ltd. (300049.SZ)
  • Jiangsu Bicon Pharmaceutical Listed Company (002411.SZ)
  • Jiangsu Nhwa Pharmaceutical Co., Ltd. (002262.SZ)
  • Jiangsu Sihuan Bioengineering Co., Ltd. (000518.SZ)
  • Jiangxi Fushine Pharmaceutical Co., Ltd. (300497.SZ)
  • Jilin Aodong Pharmaceutical Group Co., Ltd. (000623.SZ)
  • Jilin Jian Yisheng Pharmaceutical Co., Ltd. (002566.SZ)
  • Jilin Zixin Pharmaceutical Industrial Co., Ltd. (002118.SZ)
  • Jinghua Pharmaceutical Group Co., Ltd. (002349.SZ)
  • Jingxin Pharmaceutical Co., Ltd. (002020.SZ)
  • Jinhe Biotechnology Co., Ltd. (002688.SZ)
  • Jinling Pharmaceutical Company Limited (000919.SZ)
  • Jiuzhitang Co., Ltd. (000989.SZ)
  • Kang Hong Pharmaceutical Co., Ltd. (002773.SZ)
  • Kunming Longjin Pharmaceutical Co., Ltd. (002750.SZ)
  • Lanzhou Foci Pharmaceutical Co., Ltd. (002644.SZ)
  • Livzon Pharmaceutical Group Co., Ltd. (000513.SZ)
  • Medicalsystem Biotechnology Co., Ltd. (300439.SZ)
  • Northeast Pharmaceutical Group Co., Ltd. (000597.SZ)
  • PKU Healthcare Corp., Ltd. (000788.SZ)
  • Porton Fine Chemicals Ltd. (300363.SZ)
  • Qianjiang Yongan Pharmaceutical Co., Ltd. (002365.SZ)
  • Qingdao Huaren Pharmaceutical Co., Ltd (300110.SZ)
  • Renhe Pharmacy Co., Ltd. (000650.SZ)
  • Sanjiu Medical and Pharmaceutical Co., Ltd. (000999.SZ)
  • Shandong Jincheng Pharmaceutical Co., Ltd. (300233.SZ)
  • Shandong Shanda Wit Science And Technology Co., Ltd. (000915.SZ)
  • Shandong Wohua Pharmaceutical Co., Ltd. (002107.SZ)
  • Shandong Xinhua Pharmaceutical Company Limited (000756.SZ)
  • Shanghai Kaibao Pharmaceutical Co., Ltd. (300039.SZ)
  • Shanxi C&Y Pharmaceutical Group Co., Ltd. (300254.SZ)
  • Shanxi Zhendong Pharmaceutical Co., Ltd. (300158.SZ)
  • Shenzhen Cau Technology Co., Ltd. (000004.SZ)
  • Shenzhen Hepalink Pharmaceutical Co., Ltd. (002399.SZ)
  • Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294.SZ)
  • Shenzhou Yiqiao Information Service Co., Ltd. (000606.SZ)
  • Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603.SZ)
  • Sichuan Kelun Pharamceutical Co., Ltd. (002422.SZ)
  • Sichuan Maccura Biotechnology Co., Ltd. (300463.SZ)
  • Sunflower Pharmaceutical Group Co., Ltd. (002737.SZ)
  • Teyi Pharmaceutical Group Co., Ltd. (002728.SZ)
  • Tianjin Lisheng Pharmaceutical Co., Ltd. (002393.SZ)
  • Tianjin Ringpu Bio-technology Co., Ltd. (300119.SZ)
  • Tibet Aim Pharm. Inc. (002826.SZ)
  • Tibet Cheezheng Tibetan Medicine Co., Ltd. (002287.SZ)
  • Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd. (000766.SZ)
  • Tus-Guhan Group Corp., Ltd. (000590.SZ)
  • Xiangxue Pharmaceutical Co., Ltd. (300147.SZ)
  • Yantai Dongcheng Biochemicals Co., Ltd. (002675.SZ)
  • Yifan Pharmaceutical Co., Ltd. (002019.SZ)
  • Yunnan Baiyao Group Co., Ltd. (000538.SZ)
  • Zhejiang Garden Bio-Chemical High-Tech Co., Ltd. (300401.SZ)
  • Zhejiang Hisoar Pharmaceutical Co., Ltd. (002099.SZ)
  • Zhejiang Jolly Pharmaceutical Co., Ltd. (300181.SZ)
  • Zhejiang NHU Co., Ltd. (002001.SZ)
  • Zhejiang Xianju Pharmaceutical Co., Ltd. (002332.SZ)
  • Zhejiang Xinguang Pharmaceutical Co., Ltd. (300519.SZ)
  • Zhejiang Yatai Pharmaceutical Co., Ltd. (002370.SZ)
  • Zhenxing Biopharmaceutical & Chemical Inc. (000403.SZ)
Note: Product cover images may vary from those shown
4 of 4

Background research defines the range of products and industries, which proposes the key points of the research. Proper classification will help clients understand the industry and products in the report.

Secondhand material research is a necessary way to push the project into fast progress. The analyst always chooses the data source carefully. Most secondhand data they quote is sourced from an authority in a specific industry or public data source from governments, industrial associations, etc. For some new or niche fields, they also "double-check" data sources and logics before they show them to clients.

Primary research is the key to solve questions, which largely influence the research outputs. The analyst may use methods like mathematics, logical reasoning, scenario thinking, to confirm key data and make the data credible.

The data model is an important analysis method. Calculating through data models with different factors weights can guarantee the outputs objective.

The analyst optimizes the following methods and steps in executing research projects and also forms many special information gathering and processing methods.

1. Analyze the life cycle of the industry to understand the development phase and space.
2. Grasp the key indexes evaluating the market to position clients in the market and formulate development plans
3. Economic, political, social and cultural factors
4. Competitors like a mirror that reflects the overall market and also market differences.
5. Inside and outside the industry, upstream and downstream of the industry chain, show inner competitions
6. Proper estimation of the future is good guidance for strategic planning.